Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Study of … – ACROFAN,

… announced that it had dosed the first patient with LNK01001 in its Phase II clinical trial on subjects with atopic dermatitis (AD)., … announced that it had dosed the first patient with LNK01001 in its Phase II clinical trial on subjects with atopic dermatitis (AD)., Read More

Scroll to Top